BMGL · Basel Medical Group Ltd Ordinary Shares

Summary

Basel Medical Group Ltd announced on March 24, 2026, that Nasdaq has determined compliance with the periodic filing requirement under Listing Rule 5250(c)(1) based on the company's amended annual report on Form 20-F for fiscal year 2025, filed with the SEC on March 13, 2026. This resolves the prior deficiency relating to the Periodic Filing Rule.

Key takeaways

• Nasdaq notification received confirming compliance with Listing Rule 5250(c)(1)
• Compliance based on amended Form 20-F for fiscal year 2025 filed March 13, 2026
• Prior deficiency under Periodic Filing Rule resolved